Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jun 17, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Harrow, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 14
| |||||||
Harpoon Therapeutics, Inc.
| -5.00K |
—
|
—
| -100.00% |
0
|
Mar 11
| |||||||
Harrow, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 26
| |||||||
Harrow, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Harpoon Therapeutics, Inc.
| 5K |
—
|
—
|
∞
| 5K |
Nov 27
| |||||||
Harpoon Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 22
| |||||||
Harpoon Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Sep 15
| |||||||
Harpoon Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Evolus, Inc.
| -68.20K |
$12.78 | -$871,380.42 | -32.51% | 141.57K |
May 17 - May 18
| |||||||
Evolus, Inc.
| -10.19K |
$9.73 | -$99,121.28 | -4.63% | 209.78K |
Mar 8
|
Scheduled
| ||||||
Evolus, Inc.
| 53.57K |
—
|
—
| +32.19% | 219.97K |
Jan 24
| |||||||
Evolus, Inc.
| -14.29K |
$11.18 | -$159,774.30 | -7.91% | 166.4K |
Aug 10
|
Scheduled
| ||||||
Evolus, Inc.
| 14.29K |
$11.18 | $159,774.30 | +7.91% | 194.98K |
Aug 10
|
Scheduled
| ||||||
Evolus, Inc.
| 90K |
—
|
—
| +99.24% | 180.69K |
Jan 27
| |||||||
Evolus, Inc.
| -2.70K |
$7.46 | -$20,134.54 | -2.89% | 90.69K |
Jan 25
|
Scheduled
| ||||||
Evolus, Inc.
| 40K |
—
|
—
| +74.92% | 93.39K |
May 13
| |||||||
Evolus, Inc.
| 26K |
—
|
—
| +94.93% | 53.39K |
Jan 23
| |||||||
Evolus, Inc.
| -2.61K |
$13.53 | -$35,352.11 | -8.71% | 27.39K |
May 31
| |||||||
Evolus, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 23
| |||||||
Evolus, Inc.
| 30K |
—
|
—
|
∞
| 30K |
May 29
| |||||||
Evolus, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Revance Therapeutics, Inc.
| -2.87K |
$30.25 | -$86,924.42 | -4.20% | 65.5K |
May 22
|
Scheduled
| ||||||
Revance Therapeutics, Inc.
| -3.43K |
$30.85 | -$105,838.80 | -4.78% | 68.37K | +1 |
Mar 22
|
Scheduled
| |||||
Revance Therapeutics, Inc.
| -1.15K |
$21.54 | -$703,829.40 | -1.58% | 71.8K | +1 |
Mar 13 - Mar 15
|
Scheduled
| |||||
Revance Therapeutics, Inc.
|
0
|
$20.35 | -$466,000.00 |
—
| 72.95K | +1 |
Mar 7 - Mar 9
|
Scheduled
| |||||
Revance Therapeutics, Inc.
| -1.14K |
$31.75 | -$36,068.00 | -1.53% | 72.95K | +1 |
Feb 15
| ||||||
Revance Therapeutics, Inc.
| 8.13K |
—
|
—
| +12.32% | 74.09K | +1 |
Feb 8
| ||||||
Revance Therapeutics, Inc.
| -990.00 |
$33.50 | -$33,165.00 | -1.48% | 65.97K | +1 |
Jan 28
| ||||||
Revance Therapeutics, Inc.
| 443 |
$22.99 | $10,185.68 | +0.67% | 66.95K | +1 |
Dec 29
| ||||||
Revance Therapeutics, Inc.
| 17.51K |
$8.70 | $152,302.20 | +35.72% | 66.51K | +1 |
Dec 26
| ||||||
Revance Therapeutics, Inc.
|
0
|
$17.77 | -$181,267.00 |
—
| 49.01K | +1 |
Nov 7
|
Scheduled
| |||||
Revance Therapeutics, Inc.
| -11.16K |
$26.67 | -$297,759.51 | -18.55% | 49.01K | +1 |
Oct 12
|
Scheduled
| |||||
Revance Therapeutics, Inc.
| 604 |
$18.32 | $11,063.77 | +1.01% | 60.17K | +1 |
Jun 30
| ||||||
Revance Therapeutics, Inc.
| 23K |
$8.70 | $200,100.00 | +62.90% | 59.57K | +1 |
May 26
| ||||||
Revance Therapeutics, Inc.
| -1.79K |
$20.20 | -$36,212.15 | -4.67% | 36.57K | +1 |
May 22
| ||||||
Revance Therapeutics, Inc.
| -1.27K |
$19.20 | -$24,365.82 | -3.20% | 38.36K | +1 |
Mar 16
| ||||||
Revance Therapeutics, Inc.
| 8.94K |
$20.00 | -$21,260.00 | +29.12% | 39.63K | +1 |
Jan 26 - Jan 28
| ||||||
Revance Therapeutics, Inc.
| 749 |
$11.56 | $8,658.44 | +2.50% | 30.69K | +1 |
Jun 30
| ||||||
Revance Therapeutics, Inc.
| -1.75K |
$17.11 | -$29,993.83 | -5.53% | 29.94K | +1 |
May 19
| ||||||
Revance Therapeutics, Inc.
| 10K |
—
|
—
| +46.09% | 31.7K | +1 |
Feb 2
| ||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.